MONTREAL, Jan. 8, 2024 /PRNewswire/ - Cannara Biotech Inc. ("Cannara" or the "Company") (TSXV:LOVE) (OTCQB:LOVFF) (FRA: 8CB), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced it has retained Independent Trading Group ("ITG") to provide market making services in accordance with TSX Venture Exchange policies.
ITG will trade the securities of the Company on the TSXV for the purpose of maintaining an orderly market. ...